Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment

Qi Zhang; Xiangdong Guo; Yingnan Cheng; Lalit Chudal; Nil Kanatha Pandey; Jieyou Zhang; Lun Ma; Qing Xi; Guangze Yang; Ying Chen; Xin Ran; Chengzhi Wang; Jingyi Zhao; Yan Li; Li Liu; Zhi Yao; Wei Chen; Yuping Ran; Rongxin Zhang

doi:10.1038/s41392-020-0156-4

Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment

Qi Zhang, Xiangdong Guo, Yingnan Cheng, Lalit Chudal, Nil Kanatha Pandey, Jieyou Zhang, Lun Ma, Qing Xi, Guangze Yang, Ying Chen, Xin Ran, Chengzhi Wang, Jingyi Zhao, Yan Li, Li Liu, Zhi Yao, Wei Chen, Yuping Ran, Rongxin Zhang

Research output: Contribution to journal › Letter › peer-review

44 Scopus citations

Original language	English (US)
Article number	58
Journal	Signal Transduction and Targeted Therapy
Volume	5
Issue number	1
DOIs	https://doi.org/10.1038/s41392-020-0156-4
State	Published - Dec 1 2020

ASJC Scopus subject areas

Genetics
Cancer Research

Access to Document

10.1038/s41392-020-0156-4

Cite this

Zhang, Q., Guo, X., Cheng, Y., Chudal, L., Pandey, N. K., Zhang, J., Ma, L., Xi, Q., Yang, G., Chen, Y., Ran, X., Wang, C., Zhao, J., Li, Y., Liu, L., Yao, Z., Chen, W., Ran, Y., & Zhang, R. (2020). Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment. Signal Transduction and Targeted Therapy, 5(1), Article 58. https://doi.org/10.1038/s41392-020-0156-4

Zhang, Q, Guo, X, Cheng, Y, Chudal, L, Pandey, NK, Zhang, J, Ma, L, Xi, Q, Yang, G, Chen, Y, Ran, X, Wang, C, Zhao, J, Li, Y, Liu, L, Yao, Z, Chen, W, Ran, Y & Zhang, R 2020, 'Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment', Signal Transduction and Targeted Therapy, vol. 5, no. 1, 58. https://doi.org/10.1038/s41392-020-0156-4

@article{b035386d5cad4814899a98939112020a,

title = "Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment",

author = "Qi Zhang and Xiangdong Guo and Yingnan Cheng and Lalit Chudal and Pandey, {Nil Kanatha} and Jieyou Zhang and Lun Ma and Qing Xi and Guangze Yang and Ying Chen and Xin Ran and Chengzhi Wang and Jingyi Zhao and Yan Li and Li Liu and Zhi Yao and Wei Chen and Yuping Ran and Rongxin Zhang",

note = "Funding Information: This work was supported by the National Natural Science Foundation of China through No. 81872320, 31600730, 81602496, and 81272317 and the Innovation and University Promotion Project of Guangdong Pharmaceutical University through No. 2017KCXTD020. W.C. would like to acknowledge the supports from Suzhou Jailuoyuan Inc. and Solgro Inc. as well as the Distinguished record award in research/creative activity from the University of Texas in Arlinton.",

year = "2020",

month = dec,

day = "1",

doi = "10.1038/s41392-020-0156-4",

language = "English (US)",

volume = "5",

journal = "Signal Transduction and Targeted Therapy",

issn = "2095-9907",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment

AU - Zhang, Qi

AU - Guo, Xiangdong

AU - Cheng, Yingnan

AU - Chudal, Lalit

AU - Pandey, Nil Kanatha

AU - Zhang, Jieyou

AU - Ma, Lun

AU - Xi, Qing

AU - Yang, Guangze

AU - Chen, Ying

AU - Ran, Xin

AU - Wang, Chengzhi

AU - Zhao, Jingyi

AU - Li, Yan

AU - Liu, Li

AU - Yao, Zhi

AU - Chen, Wei

AU - Ran, Yuping

AU - Zhang, Rongxin

N1 - Funding Information: This work was supported by the National Natural Science Foundation of China through No. 81872320, 31600730, 81602496, and 81272317 and the Innovation and University Promotion Project of Guangdong Pharmaceutical University through No. 2017KCXTD020. W.C. would like to acknowledge the supports from Suzhou Jailuoyuan Inc. and Solgro Inc. as well as the Distinguished record award in research/creative activity from the University of Texas in Arlinton.

PY - 2020/12/1

Y1 - 2020/12/1

UR - http://www.scopus.com/inward/record.url?scp=85084653105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084653105&partnerID=8YFLogxK

U2 - 10.1038/s41392-020-0156-4

DO - 10.1038/s41392-020-0156-4

M3 - Letter

C2 - 32409655

AN - SCOPUS:85084653105

SN - 2095-9907

VL - 5

JO - Signal Transduction and Targeted Therapy

JF - Signal Transduction and Targeted Therapy

IS - 1

M1 - 58

ER -

Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this